ADMA Biologics
ADMA
ADMA
56 hedge funds and large institutions have $84.5M invested in ADMA Biologics in 2019 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 13 reducing their positions, and 5 closing their positions.
Holders
56
Holders Change
+4
Holders Change %
+7.69%
% of All Funds
1.21%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
15
Reduced
13
Closed
5
Calls
$297K
Puts
$1.81M
Net Calls
-$1.51M
Net Calls Change
-$1.51M
Top Buyers
Top Sellers
1 |
BC
1
Broadfin Capital
New York
|
$5.61M |
2 |
2
UBS Group
Zurich,
Switzerland
|
$5K |
3 |
DG
3
Delek Group
Herzliya,
Israel
|
$241K |
4 |
4
Morgan Stanley
New York
|
$148K |
5 |
![]()
5
JPMorgan Chase & Co
New York
|
$24K |